Your browser doesn't support javascript.
loading
A phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720.
PLoS One ; 6(9): e24413, 2011.
Article in En | MEDLINE | ID: mdl-21949716

Full text: 1 Database: MEDLINE Main subject: Plasmodium falciparum / Oleic Acids / Protozoan Proteins / Malaria Vaccines / Life Cycle Stages / Mannitol / Antigens, Protozoan Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2011 Type: Article Affiliation country: Australia

Full text: 1 Database: MEDLINE Main subject: Plasmodium falciparum / Oleic Acids / Protozoan Proteins / Malaria Vaccines / Life Cycle Stages / Mannitol / Antigens, Protozoan Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2011 Type: Article Affiliation country: Australia